Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1

Conditions

Xeroderma Pigmentosum 2Keratosis, Actinic 1Carcinoma, Squamous Cell 1

Interventions

Injections 54Cisplatin 49Paclitaxel 48Carboplatin 43Gemcitabine 38pembrolizumab 36Docetaxel 36Capecitabine 36Drug Therapy 34anlotinib 25Bevacizumab 25Fluorouracil 24Cyclophosphamide 24icotinib 23Oxaliplatin 20fludarabine 19Pemetrexed 17Leucovorin 16Irinotecan 16Temozolomide 14Nivolumab 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Trastuzumab 12Rituximab 11Fulvestrant 11Etoposide 11tesetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × afamelanotide × Clear all
NCT05370235 2023-09-21

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown
6 enrolled

Xeroderma Pigmentosum

NCT05159752 2023-06-18

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown
6 enrolled

Xeroderma Pigmentosum

NCT00829192 2010-12-06

Phase II AK Study in Organ Transplant Patients

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown
200 enrolled
Dermatologic

Carcinoma, Squamous Cell, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡